← Human Trials & Peer-Reviewed Studies

Vitamin D deficiency and associated demographic risk factors in children at a tertiary hospital in Abu Dhabi.

Plain-language guide to PMID 39246017 (2024): pilot observational study of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
39246017
Journal
Paediatrics and international child health
Year
2024
Study type
Observational Study
Authors
Abuhamad AY et al. (8 authors)
DOI
10.1080/20469047.2024.2396714

What This Study Did, in Plain Language

What Was Tested

This observational study looks at Vitamin D, K2, Magnesium and Zinc.

Despite ample sunshine, vitamin D deficiency continues to be prevalent in the Middle East.

This pilot study aimed to identify the rate of vitamin D deficiency at a tertiary hospital in Abu Dhabi and to identify the associated risk factors in children and adolescents.

Who Took Part

By PubMed's age tags, the people studied were infants, young children, children and teenagers, both men and women.

A retrospective observational study was conducted using electronic medical records of paediatric patients who underwent 25-hydroxyvitamin D testing at Sheikh Shakhbout Medical City, Abu Dhabi between 1 January 2020 and 31 December 2021.

Data on age, gender, ethnicity, weight, body mass index and other potential risk factors for vitamin D deficiency in children were recorded.

How the Study Was Run

In design terms this was a pilot study.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

Patients who were already receiving treatment for vitamin D deficiency were excluded.

The collected data were analysed using standard statistical methods.

What Was Measured

The subject headings attached to it are Vitamin D Deficiency, Tertiary Care Centers, Risk Factors, United Arab Emirates, Prevalence, Pilot Projects and Vitamin D.

The authors tagged it with the keywords body mass index, bone profile, comorbidities, environmental factors, rickets and sunlight exposure.

What This Means in Plain Language

The paper is a pilot study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (Paediatrics and international child health), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.